Zobrazeno 1 - 10
of 76
pro vyhledávání: '"E G Zotkin"'
Publikováno v:
Остеопороз и остеопатии, Vol 18, Iss 3, Pp 30-35 (2015)
This article is dedicated to the problem of creating off fracture liaison services (FLS) for patients with osteoporosis including overview of the problem and some recommendations on it. The article presents there levance of the problem discussed, giv
Externí odkaz:
https://doaj.org/article/e8f96b31286f430b8493806a4033f1ca
Autor:
M. A. Makarov, V. A. Nesterenko, V. E. Bialik, E. G. Zotkin, E. I. Bialik, S. A. Makarov, A. E. Karateev, A. A. Bialik
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 319-324 (2024)
The aim of the study – Is to evaluate the effectiveness and safety of the use of a functional unloading orthosis with the possibility of varus–valgus correction (FUOVVC) in patients with stage III osteoarthritis of the knee joint.Materials and me
Externí odkaz:
https://doaj.org/article/361b444ac9e0426e9347cb97451d1e13
Autor:
E G Zotkin
Publikováno v:
Современная ревматология, Vol 4, Iss 1, Pp 70-75 (2010)
Development Bisphosphonates are a major class of drugs used to treat osteoporosis (OP) and other diseases characterized by increased bone resorption. The literature contains indisputable evidence for the efficacy of alendronate in the registered oral
Externí odkaz:
https://doaj.org/article/651b02689b4c414e98eb3fd857b95c99
Publikováno v:
Современная ревматология, Vol 0, Iss 3, Pp 40-45 (2008)
Objective - to study the clinical efficacy and tolerability of two dosage forms of Ketorol (tablets and solution for injections) versus the similar formulations of diclofenac sodium in patients with osteoarthrosis (OA) in an open-labeled randomized s
Externí odkaz:
https://doaj.org/article/a738b6ff28044f00a2d08a0782ffd575
Autor:
E. A. Aseeva, N. S. Pokrovsky, S. K. Soloviev, E. V. Nikolaeva, N. Yu. Nikishina, E. T. Abdullin, T. M. Reshetnyak, E. G. Zotkin, A. M. Lila
Publikováno v:
Современная ревматология, Vol 18, Iss 2, Pp 75-80 (2024)
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology characterized by the overproduction of autoantibodies against various components of the nucleus of the patient's own cells with the development of immunoinflammat
Externí odkaz:
https://doaj.org/article/90502acfa030437d8a037771a7358fda
Autor:
E G Zotkin
Publikováno v:
Научно-практическая ревматология, Vol 43, Iss 5, Pp 48-51 (2005)
Brief information about modem osteoarthritis treatment with simple analgesics, NSAIDs and chondroprotective drugs is presented. Results of a clinical study of ARTRA in combination with diclofenac (31 pts) comparing with diclofenac only (31 pts) for t
Externí odkaz:
https://doaj.org/article/f33b2a8a2b5540c188e74ef9aab4c5ce
Autor:
E G Zotkin, Yu A Safonova, T V Kharitonova, L Ya Rozhinskaya, S D Arapova, L K Dzeranova, N N Molitvoslovova, A A Shishkina
Publikováno v:
Остеопороз и остеопатии, Vol 12, Iss 2, Pp 18-20 (2009)
Externí odkaz:
https://doaj.org/article/781a104bf02a41a2bf43dd2777f35c67
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 54-61 (2024)
Objective: a comparative study of the peculiarities of pharmacotherapy of rheumatoid arthritis (RA) in presence and in absence of interstitial lung disease (ILD).Material and methods. The study included 1034 patients with active RA who met the 2010 A
Externí odkaz:
https://doaj.org/article/364190841e404d9f9d1c2b4a379c8772
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 59-64 (2023)
Anemia is still one of the most common comorbidities that affects the prognosis of the underlying disease and the quality of life of patients.Objective: to evaluate the value of serum hepcidin level determination for the differential diagnosis of ane
Externí odkaz:
https://doaj.org/article/264e287253544aecb2d0f3240e91ffb8
Autor:
P. S. Kovalenko, I. S. Dydykina, O. G. Alekseeva, E. L. Shakhramanova, A. S. Potapova, S. I. Glukhova, E. G. Zotkin
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 84-91 (2023)
Ensuring a long-lasting effect of the therapy and its safety are important tasks in the treatment of patients with osteoarthritis (OA). Parenteral forms of chondroitin sulfate (CS) used for the background therapy of OA are characterized by proven eff
Externí odkaz:
https://doaj.org/article/53ac33443b234510b3b1bc9b3f05bb62